Candriam S.C.A. Arcturus Therapeutics Holdings Inc. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$14.72 - $23.97 $432,782 - $704,741	29,401 New	29,401 $704,000
Q2 2021 Jul 20, 2021	SELL	$25.79 - $42.11 $1.38 Million - $2.26 Million	-53,633 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$34.61 - $123.66 $902,871 - $3.23 Million	-26,087 Reduced 32.72%	53,633 $2.33 Million
Q2 2020 Jul 23, 2020	BUY	$12.66 - $58.27 $1.01 Million - $4.65 Million	79,720 New	79,720 $3.73 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.